BNP Paribas Financial Markets’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$53.6K Sell
6,590
-810
-11% -$6.59K ﹤0.01% 3424
2025
Q1
$58.1K Sell
7,400
-12,941
-64% -$102K ﹤0.01% 3406
2024
Q4
$303K Buy
20,341
+9,016
+80% +$134K ﹤0.01% 2804
2024
Q3
$173K Sell
11,325
-9,827
-46% -$150K ﹤0.01% 2584
2024
Q2
$322K Sell
21,152
-14,488
-41% -$221K ﹤0.01% 2225
2024
Q1
$673K Sell
35,640
-74,726
-68% -$1.41M ﹤0.01% 2068
2023
Q4
$2.11M Buy
110,366
+27,048
+32% +$517K ﹤0.01% 1377
2023
Q3
$1.5M Buy
83,318
+20,533
+33% +$369K ﹤0.01% 1506
2023
Q2
$1.28M Sell
62,785
-100,511
-62% -$2.04M ﹤0.01% 1513
2023
Q1
$2.98M Buy
163,296
+118,769
+267% +$2.17M ﹤0.01% 1140
2022
Q4
$921K Sell
44,527
-92,430
-67% -$1.91M ﹤0.01% 1616
2022
Q3
$3.58M Buy
136,957
+73,204
+115% +$1.92M 0.01% 1096
2022
Q2
$1.62M Buy
63,753
+53,291
+509% +$1.35M ﹤0.01% 1396
2022
Q1
$330K Sell
10,462
-6,789
-39% -$214K ﹤0.01% 2399
2021
Q4
$698K Buy
17,251
+5,686
+49% +$230K ﹤0.01% 2232
2021
Q3
$403K Buy
11,565
+5,879
+103% +$205K ﹤0.01% 2255
2021
Q2
$156K Buy
5,686
+74
+1% +$2.03K ﹤0.01% 2340
2021
Q1
$158K Sell
5,612
-554
-9% -$15.6K ﹤0.01% 2595
2020
Q4
$160K Sell
6,166
-4,770
-44% -$124K ﹤0.01% 2345
2020
Q3
$187K Buy
10,936
+7,483
+217% +$128K ﹤0.01% 2188
2020
Q2
$85.4K Sell
3,453
-6,574
-66% -$163K ﹤0.01% 2213
2020
Q1
$139K Buy
10,027
+2,139
+27% +$29.7K ﹤0.01% 2453
2019
Q4
$79.7K Buy
7,888
+2,857
+57% +$28.9K ﹤0.01% 2731
2019
Q3
$45.8K Sell
5,031
-120
-2% -$1.09K ﹤0.01% 2895
2019
Q2
$41K Sell
5,151
-1,370
-21% -$10.9K ﹤0.01% 2924
2019
Q1
$81.4K Buy
6,521
+6,200
+1,931% +$77.4K ﹤0.01% 2662
2018
Q4
$3.46K Buy
321
+152
+90% +$1.64K ﹤0.01% 3016
2018
Q3
$2.36K Sell
169
-1
-0.6% -$14 ﹤0.01% 3565
2018
Q2
$2.08K Buy
+170
New +$2.08K ﹤0.01% 3596